Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term immunity after yellow fever vaccination
NL-OMON39667Active, not recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Mar 2013
- Modality
- Live Attenuated Vaccines → Live Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Open-label, single-arm trial of 17D yellow fever vaccine in yellow fever, sponsored by Amsterdam University Medical Center. Primary endpoint: Protective neutralizing antibody response. Started Mar 2013; status: active, not recruiting.
02
Drugs
17D yellow fever vaccine
03
Conditions
yellow fever
Beyond the preview
Go deeper on NL-OMON39667.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON39667.